Future Pharmaceuticals

Featured articles

Pharma Photo
Improved Care a Possibility through eRT Initiatives
The future of the pharmaceutical industry is being driven by the need to not only introduce safe and effective drugs and medical devices, but to do so in the face of exceptionally demanding economic pressure and competition. Striving to meet these needs has been both challenging and rewarding for eRT.
Thermo Fisher Scientific Sails into astraZeneca with nautilus lims
Roger Clark, Senior Scientist, Cancer & Infection Department, AstraZeneca, discusses biochemical screening and the impact of Nautilus.
Ronald D. Fitzmartin
Ronald D. Fitzmartin shares how DIA has remained strong for over 40 years and why DIA is only becoming bigger and better.
Delivering a Green Solution
Eric Lindquist, President, Entropy Solutions, discusses a more efficient and green solution to shipping pharmaceutical drugs.
What Would You Like to Learn Today?
Nancy Grey, Director of Pharmacovigilance education and Process Documentation at Pfizer Inc., discusses the importance of exercising a learning needs analysis.
PsyCROlogy of Patient Recruitment and Retention
Moderated by Peter Dibiaso, Senior Clinical Operations Director, Clinical Research & Development, Shire Pharmaceuticals
Real-Time Data Access
David Spaight, President, MDS Pharma Services, discusses an innovative new study management system that gives clients access to study data anytime, anywhere
Trials & Troubles of Clinical Site Recruitment
Malcolm Bohm, President, Trialytics, discusses the frustrations of patient recruitment and methods that are combating obstacles one measure at a time.

Podcasts

Hilary M. Malone, Ph.D., Senior Vice President and Head of Global Regulatory Affairs for Wyeth and a member of the Wyeth R&D Executive Committee, leads the Regulatory Affairs division that is responsible for Wyeth research and marketed products spanning pharmaceuticals, biopharmaceuticals and vaccines.

While the pharmaceutical industry is rapidly changing, one constant that remains is the need to train and develop quality employees to ensure quality service.

Doug McLeester, VP Supply Chain at sanofi-aventis, leads this panel discussion with experts from Acsis, Inc., Microsoft’s Life Sciences division and SAP to figure out what is changing in terms of industry compliance and how organizations can...

ERIC LINDQUIST, President, Entropy Solutions, discusses a more efficient and green solution to shipping pharmaceutical drugs

p. Ranganath Nayak, Ph.D., Chief Executive Officer of Cytel Inc., gives insight into the adaptive clinical trials process.

BARBARA A. PALDUS, MARK SELKER and ALFY RIDDLE, from Finesse, discuss changes in bioprocessing.

whitepapers

With pharma companies coming under increasing pressure to improve profits and speedproduct development times, how can the industry harness technology to drive down the costof the clinical development process?
The majority of clinical studies fall behind schedule due to slower than expected patient enrollment. Traditional methods that rely on the study site to recruit patients have not evolved and continue to render disappointment that negatively affect the study and often the relationship between “investigator prescribers” and sponsors.
The Center for the Health Professions at the University of California, San Francisco, focuses its efforts on understanding and addressing the challenges faced by health care workers.
In 2000, St. Luke’s Hospital & Health Network was facing a host of industry and operational challenges ranging from staff retention to cost containment to patient satisfaction.
Every year countless businesses that appear to have all the right stuff—great vision and the operational capabilities to implement it—fail. Why? The answer is simple: They fail because they don’t have good leaders.


featured Research

EI is the ability to make the front of the brain rationalize the stimulus prior to assigning it an emotion, thereby affecting the way we look at ourselves and others.
The success of recombinant DNA technology derived biopharmaceuticals has necessitated the construction of large manufacturing plants...
Robert Abraham, Vice President of Oncology at Wyeth Research, provides powerful insight into new methods of preclinical cancer research and the implications it holds for the future of oncology.
Why is the exercise of a learning needs analysis (LNA) so important? Organizations blindly create training for many reasons.
How a firm & its supply chain professionals can enhance their organization by maintaining robust frameworks...
 

Thought Leadership bios

Patrick Caubel is currently Head of the North America Pharmacovigilance Department for Sanofi Pasteur in Switfwater, PA.
David Lester is New York Site head of WorldWide Clinical Technology at PGRD
Dr. Nancy Grey is Director, Pharmacovigilance Education and Process Documentation in the Safety and Risk Management organization at Pfizer, Inc.
Trudy M. Wonder manages the corporate HR communications department for Merck & Co.
Carol Rozwell is a Vice President and Distinguished Analyst in the Manufacturing Industry vertical at Gartner.

affiliate media events